9 Pharmaceuticals Stocks to Buy Now

Advertisement

The grades of 9 Pharmaceuticals stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

This week, Revance Therapeutics, Inc.’s (RVNC) ratings are up from a B last week to a A. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of RVNC stock.

Dipexium Pharmaceuticals, Inc. (DPRX) improves from a C to a B rating this week. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of DPRX stock.

Juniper Pharmaceuticals, Inc.’s (JNP) ratings are looking better this week, moving up to a A from last week’s B. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of JNP stock.

SciClone Pharmaceuticals, Inc. (SCLN) shows solid improvement this week. The company’s rating rises from a C to a B. SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The company also gets A’s in sales growth, earnings growth, and return on equity. For more information, get Portfolio Grader’s complete analysis of SCLN stock.

The rating of Agile Therapeutics, Inc. (AGRX) moves up this week, rising from a C to a B. For more information, get Portfolio Grader’s complete analysis of AGRX stock.

TherapeuticsMD, Inc. (TXMD) earns a A this week, jumping up from last week’s grade of B. TherapeuticsMD, Inc. operates as a women’s healthcare product company in the United States. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of TXMD stock.

Novogen Limited Sponsored ADR (NVGN) is seeing ratings go up from a C last week to a B this week. Novogen Limited Sponsored ADR is a medical services company which develops and markets pharmaceutical products in Australia. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of NVGN stock.

Pain Therapeutics, Inc. (PTIE) boosts its rating from a C to a B this week. Pain Therapeutics, Inc. develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of PTIE stock.

This week, Aoxing Pharmaceutical Company, Inc. (AXN) pushes up from a B to a A rating. Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. The company also gets A’s in sales growth and return on equity. For more information, get Portfolio Grader’s complete analysis of AXN stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/11/9-pharmaceuticals-stocks-to-buy-now-2/.

©2024 InvestorPlace Media, LLC